IRIS UniCatt

Gagliardini, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.010
NA - Nord America 982
AS - Asia 524
SA - Sud America 115
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 2.649
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 949
SG - Singapore 257
DE - Germania 223
PL - Polonia 209
FR - Francia 149
SE - Svezia 149
CN - Cina 131
IT - Italia 104
BR - Brasile 95
UA - Ucraina 47
GB - Regno Unito 40
IN - India 36
IE - Irlanda 30
VN - Vietnam 24
ID - Indonesia 19
FI - Finlandia 17
CA - Canada 16
RU - Federazione Russa 15
AR - Argentina 11
TR - Turchia 11
BD - Bangladesh 10
HK - Hong Kong 9
MX - Messico 9
JP - Giappone 8
NL - Olanda 7
ZA - Sudafrica 6
IR - Iran 5
JM - Giamaica 5
BE - Belgio 4
SA - Arabia Saudita 4
LT - Lituania 3
AT - Austria 2
AU - Australia 2
CL - Cile 2
DK - Danimarca 2
EC - Ecuador 2
ES - Italia 2
EU - Europa 2
MA - Marocco 2
PA - Panama 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
CO - Colombia 1
EE - Estonia 1
EG - Egitto 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MM - Myanmar 1
MT - Malta 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.649
Salva come PNG Salva come JPEG
Città #
Kraków 199
Chandler 183
Singapore 108
Ashburn 70
Jacksonville 51
New York 48
Beijing 30
Dublin 30
Redmond 30
San Mateo 29
Los Angeles 27
Milan 27
Houston 23
Ann Arbor 20
Jakarta 19
Dallas 18
Nanjing 18
Boston 17
Dearborn 17
Wilmington 15
Nürnberg 14
Cattolica 13
Lawrence 12
Rome 12
Changsha 11
Lancaster 11
The Dalles 10
Woodbridge 10
Ho Chi Minh City 9
Nanchang 9
Buffalo 8
Fairfield 8
Frankfurt am Main 8
Hong Kong 8
Roubaix 8
Seattle 8
Hanoi 7
Izmir 7
Montreal 7
Redwood City 7
Warsaw 7
Atlanta 6
Kunming 6
Munich 6
Princeton 6
Pune 6
São Paulo 6
Tokyo 6
Bexley 5
Johannesburg 5
Marseille 5
Santa Clara 5
Shenyang 5
Toronto 5
Verona 5
Washington 5
Amsterdam 4
Augusta 4
Brooklyn 4
Brussels 4
Falls Church 4
Hebei 4
Lauterbourg 4
Mexico City 4
Orem 4
Paris 4
Stockholm 4
Boardman 3
Cambridge 3
Clearwater 3
Hangzhou 3
Helsinki 3
Jinan 3
Kingston 3
Leawood 3
London 3
Manchester 3
Phoenix 3
Portsmouth 3
San Francisco 3
Turin 3
University Park 3
Andover 2
Ankara 2
Anápolis 2
Araçatuba 2
Bari 2
Biên Hòa 2
Brasília 2
Bremen 2
Calgary 2
Chennai 2
Cupertino 2
Córdoba 2
Dhaka 2
Franca 2
Fuzhou 2
Guangzhou 2
Guarulhos 2
Henderson 2
Totale 1.380
Salva come PNG Salva come JPEG
Nome #
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 213
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 211
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 206
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 200
Safety and therapeutic efficacy of the switch to maraviroc+darunavir/ritonavir in HIV/HCV coinfected patients: initial results from GUSTA study 181
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 181
Ophthalmic artery resistance index IS increased in HIV-Infected patients and is influenced by protease inhibitors exposure 171
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 159
Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients 141
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 136
Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study 129
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 125
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 120
Liver fibrosis progression and clinical outcomes are intertwined: Role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCVcoinfected patients with detectable HCV-RNA A MASTER cohort study 111
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 107
Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study 103
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir 99
Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors 76
Totale 2.669
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.057
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 7 3 1 19 4 17 2
2021/2022204 4 11 4 17 6 15 4 36 14 29 26 38
2022/2023426 66 69 29 68 28 55 7 50 44 1 8 1
2023/2024205 6 63 4 23 12 50 14 1 0 2 22 8
2024/2025360 3 14 21 11 40 7 8 29 73 25 70 59
2025/2026493 130 10 40 112 174 27 0 0 0 0 0 0
Totale 2.669